UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine
ISSN 2079-0325(p)
DOI 10.36927/2079-0325

The value of proteins in liquor and blood serum in patients with progressive courses of multiple sclerosis

Type of Article

In the Section

Index UDK:

Abstract

We have studied the indexes of albumin’s value and IgG immunoglobulin in the blood serum and in the cerebrospinal fl uid in order to determine the peculiarities of functioning of bloodbrain barrier (BBB) in 280 patients within diff erent courses of multiple sclerosis. We assessed the value of albumin and IgG immunoglobulin considering the course of the disease, the stage of process’s activity (at stages of progression and stabilization), the gender-sensitive issue, the duration of the disease, the severity of neurological defi cit according to the EDSS scale. We have showed that the degree of BBB permeability predominantly related to the stage of the process’s activity. The BBB permeability was much less aff ected by the course of the disease. Such indicators as gender, the duration of the disease and the severity of neurological defi cit according to the EDSS scale actually do not have any infl uence.

Pages

References

  1. Lijieva, R. & T. Specific Proteins of Nervous Tissue in the Assessment of Blood-Brain Barrier Permeability in Comatose States in Children: Abstract of a dissertation submitted in partial fulfillment of the requirements for the degree of Candidate of Medical Sciences. Moscow, 1990. 24 pp.
  2. Mishchenko, V. A., Goryukhina, O. A. Structure, permeability of the blood-brain barrier, and prospects for drug delivery across it // Journal of Neurology and Psychiatry. 1996. Vol. 96, No. 4. pp. 116–128.
  3. Bates D. A  new look at  the effectiveness of  natalizumab in multiple sclerosis // International Journal of Neurological. 2011. No. 7 (46). С. 21—29.
  4. Claudio L., Raine  C. S., Brosnan C.  F. Evidence of persistent blood-brain barrier abnormalities in chronic-progressive multiple sclerosis  // Acta Neuropathology. 1995. Vol. 90, No.  3. P. 228—238.
  5. Vascular aspects of  multiple sclerosis  / [M. D’haeseleer, M. Cambron, L. Vanopdenbosch, J. De Keyser] // The Lancet neurol. 2012. No. 8 (41). Р. 26—37.
  6. Havla J., Gerdes L. A., Meinl I. De-escalation from natalizumab in multiple sclerosis: recurrence of disease activity despite switching to glatiramer acetate // J. Neurol. 2011. No. 58 (9). Р. 1665—1669.
  7. Nag S. The Blood-Brain Barrier: Biology and Research Protocols // Springer, Methods in Molecular Biology. 2011. Vol. 686. Р. 518.